Research

Hormonal

Oral administration of viable Akkermansia muciniphila reverses high-fat diet-induced obesity, metabolic endotoxemia, and insulin resistance in mice by restoring gut barrier function and increasing intestinal endocannabinoids.

This research suggests that consuming live Akkermansia muciniphila, potentially through specific fermented foods or future supplements, may help improve gut health and metabolic function in individuals prone to obesity and insulin resistance. However, current evidence is from animal studies, so human application requires further clinical validation. Focus on a balanced diet rich in prebiotics (like oligofructose) which may naturally support the growth of this beneficial bacterium.

GoodSupportsHIGH confidence
A. muciniphila treatment reversed high-fat diet-induced metabolic disorders, including fat-mass gain, metabolic endotoxemia, adipose tissue inflammation, and insulin resistance.
Amandine Everard et al. · Proceedings of the National Academy of Sciences · 2013

Why this rating

High-quality animal study with clear mechanistic pathways and dose-response (viable vs heat-killed), but results are not directly translatable to humans without further clinical trials.

Source

Cross-talk between <i>Akkermansia muciniphila</i> and intestinal epithelium controls diet-induced obesity

Amandine Everard et al. · Proceedings of the National Academy of Sciences · 2013

DOI 10.1073/pnas.1219451110

mechanism_onlyCited 4,404×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →